Philotimo Fund, LP - 15 May 2025 SCHEDULE 13G/A Report for AYTU BIOPHARMA, INC Common Stock, par value $0.0001 per share (AYTU)

Filing Manager
Philotimo Fund, LP
Reporting Manager
Kanen Wealth Management LLC
Security
AYTU BIOPHARMA, INC Common Stock, par value $0.0001 per share
Symbol
AYTU
Shares outstanding
6,165,757 shares
Disclosed Ownership
635,073 shares
Ownership
10%
Form type
SCHEDULE 13G/A
Filing time
26 Jun 2025, 17:18:08 UTC
Date of event
15 May 2025
Previous filing
26 Jun 2025
Next filing
26 Jun 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Philotimo Fund, LP 6.9% 425,500 0 425,500 /s/ David L. Kanen David L. Kanen, Managing Member of Kanen Wealth Management, LLC, its general partner
Philotimo Focused Growth & Income Fund 3.4% 209,573 0 209,573 /s/ David L. Kanen David L. Kanen, Managing Member of Kanen Wealth Management, LLC, its investment manager
Kanen Wealth Management LLC 10% 635,073 0 635,073 /s/ David L. Kanen David L. Kanen, Managing Member
Kanen David 10% 635,073 0 635,073 /s/ David L. Kanen David L. Kanen